why choose us

First received: October 27, 2023

Clinical Trial: A Study of TAK-279 in Healthy Chinese Adults

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Volunteers

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Double-Blinded, Placebo-Controlled, Single and Multiple Oral Doses Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of TAK-279 in Healthy Chinese Subjects

Brief Summary: The main aim of this study is to find out how the body of a healthy Chinese adult processes TAK-279 (pharmacokinetics).Other aims are to learn about side effects and how well TAK-279 is tolerated when given to healthy Chinese Adults.Participants will receive either TAK-279 or a placebo on Day 1 and from Day 6 to Day 19.Blood samples will be taken at different timepoints throughout the study participation.Participants will need to adhere to certain lifestyle restrictions during the study.This also includes eating…

Read more